VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 66 filers reported holding VYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,421 | -32.9% | 89,472 | 0.0% | 0.00% | – |
| Q3 2022 | $20,000 | -42.9% | 89,472 | 0.0% | 0.00% | – |
| Q2 2022 | $35,000 | -39.7% | 89,472 | 0.0% | 0.00% | – |
| Q1 2022 | $58,000 | -36.3% | 89,472 | -0.0% | 0.00% | – |
| Q4 2021 | $91,000 | -57.3% | 89,477 | -41.7% | 0.00% | – |
| Q3 2021 | $213,000 | -38.4% | 153,553 | +55.9% | 0.00% | – |
| Q2 2021 | $346,000 | -87.1% | 98,524 | -74.9% | 0.00% | -100.0% |
| Q1 2021 | $2,692,000 | – | 393,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 400,000 | $2,738,000 | 6.10% |
| DSC Advisors, L.P. | 1,038,145 | $7,106,000 | 4.40% |
| CM Management, LLC | 143,750 | $984,000 | 0.73% |
| Perceptive Advisors | 6,773,954 | $46,368,000 | 0.59% |
| DELTEC ASSET MANAGEMENT LLC | 441,491 | $3,022,000 | 0.45% |
| Perennial Investment Advisors, LLC | 35,000 | $240,000 | 0.10% |
| Tekla Capital Management LLC | 135,395 | $927,000 | 0.03% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 10,051 | $69,000 | 0.02% |
| AXA S.A. | 882,124 | $6,038,000 | 0.02% |
| STALEY CAPITAL ADVISERS INC | 25,000 | $171,000 | 0.01% |